Assessing the Mechanism of Fluoxetine-Mediated CYP2D6 Inhibition

by Malavika Deodhar, Sweilem B. Al Rihani, Lucy Darakjian, Jacques Turgeon, Veronique Michaud
Published 2021-01-01

ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System

by Veronique Michaud, Malavika Deodhar, Meghan Arwood, Sweilem B Al Rihani, Pamela Dow, Jacques Turgeon
Published 2020-07-01

Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

by Sweilem B. Al Rihani, Lucy I. Darakjian, Malavika Deodhar, Pamela Dow, Jacques Turgeon, Veronique Michaud
Published 2021-04-01

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs

by Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon
Published 2021-01-01

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

by Yazan S. Batarseh, Quoc-Viet Duong, Youssef M. Mousa, Sweilem B. Al Rihani, Khaled Elfakhri, Amal Kaddoumi
Published 2016-03-01

Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy

by Sweilem B. Al Rihani, Matt K. Smith, Ravil Bikmetov, Malavika Deodhar, Pamela Dow, Jacques Turgeon, Veronique Michaud
Published 2020-08-01

Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice

by Malavika Deodhar, Sweilem B Al Rihani, Meghan J. Arwood, Lucy Darakjian, Pamela Dow, Jacques Turgeon, Veronique Michaud
Published 2020-09-01